trending Market Intelligence /marketintelligence/en/news-insights/trending/m6k01c2lw1i1zzm_hdik6a2 content esgSubNav
In This List

CytRx attracts $7M investment

Blog

Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy


CytRx attracts $7M investment

CytRx Corp. has attracted a $7 million investment from certain institutional investors who will buy 5,600,000 shares of the company at $1.25 each.

CytRx intends to use the money for working capital and general corporate purposes, including possible new drug discovery activities and acquisitions or mergers.

The offering is expected to close by May 15 with H.C. Wainwright & Co. acting as the exclusive placement agent.

The company is developing cancer treatments.